Pethidine or meperidine is sold under the brand name of Demerol and it is a synthetic opioid pain medication of phenylpiperidine class. Meperidine is indicated for the treatment of moderate to severe pain. It can be administered as hydrochloride salt in tablets, as a syrup or by intramuscular, subcutaneous or intravenous injection. Due to its toxic metabolite, norpethidine, it is more toxic than other opioid in long term usage. The metabolite of drug has serotonergic effect that could contribute to serotonin syndrome. Meperidine is a widely used opioid in labor and delivery. Meperidine is the preferred painkiller for diverticulitis because it decreases the intestinal intraluminal pressure. This drug is also used for the management of shivering during therapeutic hypothermia, as it provides the greatest reduction in the shivering threshold. It is probable that meperidine can also interact with a number of other medications including muscle relaxants, benzodiazepines, and ethanol. The adverse effects of meperidine administration are primarily those of the opioids as a class: nausea, vomiting, dizziness, diaphoresis, urinary retention, and constipation.

Market Dynamics:

The increasing demand for meperidine, research and development activities in synthesis of meperidine, and the launch of new products are attributed to the growth of the global meperidine (Demerol) market. For instance, according to data shared by European statistical System, a European government agency, on July 2022, at least 1.12 million caesarean sections were performed in the European Union in year 2020. Meperidine is a commonly used drug for the treatment of labor pain and operations. Hence increased surgeries can increase the demand for meperidine and boost the market growth over the forecast period.

Key features of the study:

• This report provides an in-depth analysis of the global Meperidine (Demerol) market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global Meperidine (Demerol) market based on the following parameters - Company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Pfizer, Inc., Hikma Pharmaceuticals USA Inc., Epic Pharma, Inc., Vintage Pharmaceuticals, Inc., Sanofi, Janssen Pharmaceuticals, Boehringer Ingelheim, Sun Pharmaceutical, Egalet Corporation, and Mallinckrodt Pharmaceuticals.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global Meperidine (Demerol) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Meperidine (Demerol) market

Detailed Segmentation:

• Global Meperidine (Demerol) Market, By Form :
  • Tablet
  • Injection
  • Syrup
• Global Meperidine (Demerol) Market, By Application :
  • Anesthesia
  • Cough Treatment
  • Diarrhea Treatment
• Global Meperidine (Demerol) Market, By Distribution Channel :
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Meperidine (Demerol) Market, By Region:
  • North America
    
    • U.S.
    • Canada
  • Latin America
    
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    
    • South Africa
    • Central Africa
    • North Africa
• Company Profiles
  • Pfizer, Inc.
  • Hikma Pharmaceuticals USA Inc.
  • Epic Pharma, Inc.
  • Vintage Pharmaceuticals, Inc.
  • Sanofi
  • Janssen Pharmaceuticals
  • Boehringer Ingelheim
  • Sun Pharmaceutical
  • Egalet Corporation
  • Mallinckrodt Pharmaceuticals